Trial Profile
GLP-1 Agonist and Bone: Effects of Exenatide on Bone Metabolism
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms GAB-E
- 29 Sep 2017 Status changed from recruiting to discontinued.
- 05 Jan 2015 New trial record